REVB (Revelation Biosciences Inc) Sof foyda

REVB (Revelation Biosciences, Inc.) - kompaniyaning tovar belgisi

Revelation Biosciences immunologik dori vositalarini yaratishni avtomatlashtirish uchun sun'iy intellekt va robototexnikani joriy qilmoqda. Kompaniyaning moliyaviy natijalari joriy biznes barqarorligini namoyish etmoqda, bunda -0.02 eng so'nggi metrika ko'rsatkichini ifodalaydi. Korxona klinik sinovlarda raqobatchilardan o'zib ketishni maqsad qilgan, shu bilan birga rahbariyat strategik hamkorlarni jalb qilish uchun tug'ma immunitetni faollashtiruvchi terapiyalarni ishlab chiqishga e'tibor qaratmoqda.

REVB (Revelation Biosciences) Sof foyda tarixi 04.07.2022dan 31.10.2026gacha

Revelation Biosciences, Inc. (REVB) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Revelation Biosciences Corp|REVB - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Revelation Biosciences Corp|REVB - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Revelation Biosciences|REVB - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi revbiosciences.com|REVB - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Revelation Biosciences|REVB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Revelation Biosciences Inc|REVB - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Revelation Biosciences Corp|REVB - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Revelation Biosciences|Shoshilinch likvidlik revbiosciences.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
REVB - Kompaniyaning sof foydasi
Kompaniyaning jamlanma tahlili:Revelation Biosciences
Revelation Bio asosiy tovari

Biofarmatsevtika startapi Revelation Biosciences (REVB) uchun ushbu ko'rsatkich dori vositalari tijoratlashtirilgunga qadar mavjud resurslarning sarflanish sur'atini kuzatish vositasi bo'lib xizmat qiladi. Kompaniyaning foydasini tahlil qilish orqali investor sof daromadning kunlik narx harakatlarini baholaydi, bunda ijobiy impulsning yo'qligi va to'xtab qolgan tendentsiya chizig'i operatsion biznes samaradorligidan ko'ra kapital sarfining o'ziga asoslangan yashab qolish modelini tasdiqlaydi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|PGEN - Kompaniyaning sof foydasi|Yakuniy foyda PHAR (Pharming Corp)|NKTR: Sof foyda|Kompaniyaning sof daromadi upstreambio.com (UPB)|Sof daromad ZBIO|Kompaniyaning sof foydasi IMNM|Sof foyda GOSS|KALV - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Septerna Inc SEPN|pieris.com - Kompaniyaning sof foydasi|Savara - Sof foyda|RIGL - Sof foyda|ANAB (AnaptysBio Corp) - Sof daromad|ATXS: Soliqlar to‘langandan keyingi foyda|ENGN (enGene Holdings Inc.) - Sof foyda|rapt.com (RAPT) - Sof moliyaviy natija|Kompaniyaning sof foydasi Aerovate Therapeutics Inc (JBIO)|ACRS - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Kyverna KYTX|TLSA: Kompaniya foydasi|CABA: Sof daromad|Yakuniy foyda VTYX (ventyxbio.com)|THTX: Sof foyda|AVTX (Avalo Therapeutics, Inc.) - Kompaniyaning sof foydasi|ELDN (Eledon) - Sof foyda|Agenus, Inc (AGEN) - Sof moliyaviy natija|Kompaniyaning sof foydasi Climb Bio Inc (CLYM)|ZURA - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi aTyr Pharma ATYR|Sof moliyaviy natija Adagene Inc (ADAG)|Ikena Oncology, Inc. - Sof foyda|Shattuck Labs, Inc. (STTK) - Sof daromad|EQ: Sof foyda|CNTB - Sof moliyaviy natija|IMUX (Immunic Therapeutics) - Sof foyda|Kompaniyaning sof daromadi Atara Biotherapeutics Inc ATRA|Kompaniyaning sof foydasi InflaRx N.V. (IFRX)|X4 Pharmaceuticals, Inc - Kompaniya foydasi|Sof foyda ACET (Adicet Bio, Inc.)|CELU - Sof daromad|INmune Bio - Sof foyda|Kompaniyaning sof daromadi Barinthus Biotherapeutics PLC|Kezar Life Sciences, Inc (KZR) - Kompaniyaning sof foydasi|SABS - Sof moliyaviy natija|Kompaniyaning sof foydasi Akari Therapeutics|ENLV: Yakuniy foyda|Sof foyda QTTB|GOVX - Kompaniyaning sof daromadi|Edesa - Sof daromad|iBio Corporation - Kompaniyaning sof foydasi|Carisma Tx - Sof foyda|XTLB: Kompaniyaning sof foydasi|boltbio.com (BOLT) - Kompaniyaning sof foydasi|Soliqdan keyingi foyda HCWB (HCW Biologics)|APVO (Aptevo Therapeutics, Inc.) - Sof foyda|AIM: Yakuniy foyda|Sof foyda ADTX|Sof foyda gribio.com (GRI)|Kompaniyaning sof foydasi XORTX Therapeutics XRTX|Yakuniy foyda HIND|INDP - Kompaniyaning sof foydasi|BiondVax Pharmaceuticals (SCNI) - Sof daromad|CALI: Sof foyda|Affimed N.V. (AFMD) - Sof foyda|Sof daromad ALLK|HOOK: Yakuniy foyda|Sof foyda IGMS|Sof moliyaviy natija iTeos Pharma|Kompaniyaning sof foydasi Ocean Biomedical, Inc. OCEA|TCBP - Sof daromad|THRD - Kompaniyaning sof foydasi